Evidence map›Paper›PMID 17005834›Full record

ArticleAntimicrobial agents and chemotherapy2006

Efficacy of ambruticin analogs in a murine model of coccidioidomycosis.

Lisa F Shubitz, John N Galgiani, Zong-Qiang Tian, Ziyang Zhong, Pieter Timmermans, Leonard Katz

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The Corey-Seebach Reagent in the 21st Century: A Review.Molecules (Basel, Switzerland) · 2023
    Review
  5. Current Landscape of Coccidioidomycosis.Journal of fungi (Basel, Switzerland) · 2022
    Review
  6. Article
  7. The antifungal pipeline: a reality check.Nature reviews. Drug discovery · 2017
    Review
  8. Large-Scale Evaluation ofAntimicrobial agents and chemotherapy · 2017
    Article
  9. Article
  10. The antifungal polyketide ambruticin targets the HOG pathway.Antimicrobial agents and chemotherapy · 2007
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lisa F ShubitzDepartment of Veterinary Science and Microbiology, University of Arizona, Tucson, AZ 85723, USA.
John N Galgiani
Zong-Qiang Tian
Ziyang Zhong
Pieter Timmermans
Leonard Katz

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ambruticin S, an antifungal cyclopropyl-pyran acid, showed curative effects against murine coccidioidal infection. Two analogs of this compound with greater in vitro potency were tested against lethal murine Coccidioides infection. Both improved the survival of mice over that of controls; one resulted in near-sterilization of infection.

Indexed as

AnimalsAntifungal AgentsCoccidioidesCoccidioidomycosisDisease Models, AnimalDrug Evaluation, PreclinicalFemaleHumansLung Diseases, FungalMiceMice, Inbred C57BLMicrobial Sensitivity TestsPyransTreatment OutcomeambruticinAntifungal AgentsPyrans

Identifiers

PMID17005834
PMCPMC1610061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.